A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

A New York roller derby league has lost its bid to temporarily block a local ban on transgender female athletes. A Nassau ...

A nationwide recall has been issued for a popular snack brand.Wismettac Asian Foods, Inc. has issued a nationwide recall of ...

Some of Donald Trump’s picks for his cabinet are expected to be confirmed by the US Senate this week after the chamber held ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

A new study by researchers from the Brown University School of Public Health found that pregnant women are regularly excluded ...

I think if we try for $2 trillion, we’ve got a good shot at getting 1 [trillion],” Musk said in a January interview.